WEBVTT

00:00:00.110 --> 00:00:11.110
It is now my absolute honor, privilege, joy, and opportunity to introduce to all of you Dr. Elizabeth L. Maloney.

00:00:11.110 --> 00:00:19.110
Dr. Maloney is a Minnesota family physician, policy consultant, and medical educator.

00:00:19.110 --> 00:00:29.110
In 2021, she was appointed to the Federal Tick-Borne Disease Working Group, a federal advisory committee on tick-borne illnesses.

00:00:29.110 --> 00:00:37.350
She served on several tick-borne disease working group subcommittees prior to her appointment from 2018 to 2020.

00:00:38.250 --> 00:00:47.170
She has also provided testimony regarding tick-borne disease to several state legislative committees and Canada Health.

00:00:47.170 --> 00:00:58.410
Since 2007, Dr. Maloney has been providing comprehensive, evidence-based, accredited continuing medical education courses.

00:00:58.790 --> 00:01:09.430
Further, she has authored several peer-reviewed papers, including grade-based treatment guidelines on Lyme disease.

00:01:09.430 --> 00:01:18.150
She also speaks to the general public on the need to consistently use effective tick-layer prevention strategies.

00:01:18.630 --> 00:01:21.290
Dr. Maloney, thank you so much for being here.

00:01:23.330 --> 00:01:34.390
Thank you. I want to thank the committee for inviting me to participate in this very wonderful event.

00:01:35.390 --> 00:01:38.730
I have no relationship with commercial interests.

00:01:38.730 --> 00:01:45.750
In my talk today, we'll highlight some of the nuances of the clinically available tests.

00:01:45.850 --> 00:01:48.930
So these are the tests that you're ordering in your clinics.

00:01:49.530 --> 00:01:54.410
So it's going to focus on serology because that's what's available right now.

00:01:54.850 --> 00:02:01.650
Before I do that, though, I'm going to review some basic principles and concepts of laboratory medicine

00:02:01.650 --> 00:02:06.810
because I want to make sure we're all on the same page as we move forward to talk about serology.

00:02:06.810 --> 00:02:15.050
and so testing is not to be put in a vacuum it's part of the diagnostic process and the first part

00:02:15.050 --> 00:02:21.090
of that process is obtaining a history and as you heard from Dr. Alcott there's a lot of questions

00:02:21.090 --> 00:02:26.990
in history to be obtained if you're thinking that someone might have Lyme disease and with a good

00:02:26.990 --> 00:02:33.890
history we can eliminate many potential diagnoses and as we work through our list and

00:02:33.890 --> 00:02:39.910
then we move to clinical exam. An exam will eliminate even more, and so you're at that

00:02:39.910 --> 00:02:45.230
phase where you are able to have a clinical impression. Now, clinical impressions and

00:02:45.230 --> 00:02:52.470
final diagnoses are often the same, but in situations where there's still some uncertainty,

00:02:52.970 --> 00:02:58.270
you can move to use testing to see if you can get to that final diagnosis.

00:02:58.270 --> 00:03:13.410
I want to point out that we have surveyed, I'm not being personally, but there have been surveys of clinicians asking them to rank the relative value of history, exam, and testing, and they did it in that order.

00:03:14.070 --> 00:03:18.710
And I think that's something to bear in mind when those three are not aligned.

00:03:21.280 --> 00:03:26.160
So the goal of diagnostic testing is to help clarify a clinical situation.

00:03:26.160 --> 00:03:32.600
situation. It's going to do that by providing additional information regarding potential

00:03:32.600 --> 00:03:39.360
diagnoses. So diagnostic testing is diagnosis-directed. It is not a fishing expedition.

00:03:40.560 --> 00:03:46.440
So in the case of Lyme disease, might diagnostic testing help when there's a tick bite or an EM

00:03:46.440 --> 00:03:54.340
rash for someone with arthritis who's been exposed to ticks? But how about people in

00:03:54.340 --> 00:04:01.340
endemic areas who have a new second degree or third degree AV block, someone who has cognitive

00:04:01.340 --> 00:04:08.420
problems and peripheral nervous system findings. Or how about the people with PLD, persistent Lyme

00:04:08.420 --> 00:04:14.580
disease? These are the people that have been treated and remain ill. So these would be similar

00:04:14.580 --> 00:04:23.440
to Dr. Ock's would testing help would work out that way. When you're selecting a test,

00:04:23.440 --> 00:04:25.760
is you want to look at various factors.

00:04:25.960 --> 00:04:28.260
So the first is, how is the test performed?

00:04:28.940 --> 00:04:29.680
Is it accurate?

00:04:29.980 --> 00:04:30.560
Is it precise?

00:04:31.460 --> 00:04:32.480
Is it available?

00:04:33.740 --> 00:04:36.200
Is it going to be a lengthy procedure?

00:04:36.360 --> 00:04:37.440
Is it a simple blood draw?

00:04:38.320 --> 00:04:40.920
How costly is it for the patient?

00:04:41.780 --> 00:04:44.480
And then how are you going to use the results?

00:04:44.480 --> 00:04:45.580
Because that matters.

00:04:46.920 --> 00:04:50.300
So you can describe a test by various characteristics,

00:04:50.300 --> 00:04:52.760
and two of them are accuracy and precision.

00:04:53.440 --> 00:04:56.760
So, accuracy gives results that are true.

00:04:57.540 --> 00:05:02.040
So, a positive test means that the patient has the disease, and a negative test means

00:05:02.040 --> 00:05:03.000
that they do not.

00:05:03.780 --> 00:05:06.460
Precision is not interested in disease state.

00:05:06.560 --> 00:05:11.320
They just want to know if the results are about the same when you repeat the test on

00:05:11.320 --> 00:05:11.640
the same.

00:05:12.540 --> 00:05:18.340
Now, the targets here are trying to demonstrate combinations of accuracy and precision.

00:05:19.060 --> 00:05:24.840
So we would want all of our disease patients to be within the target, and we would

00:05:24.840 --> 00:05:27.820
want the people who are disease-negative to be outside.

00:05:28.860 --> 00:05:33.620
They should all cluster because that represents that they're good on repeat

00:05:33.620 --> 00:05:35.120
testing, that they are all the same.

00:05:35.780 --> 00:05:38.220
So in that first, you see that there's great precision.

00:05:38.800 --> 00:05:42.620
The test results have clustered, but they're completely wrong.

00:05:42.620 --> 00:05:45.180
And so you have a precise but inaccurate.

00:05:46.140 --> 00:05:53.220
We flip it around in the middle, so now all the results are correct, but they're scattered, so they're very imprecise.

00:05:53.620 --> 00:05:59.620
And it makes you wonder how long it's going to take to have one of those results fall outside of the area where it should be.

00:06:00.140 --> 00:06:04.920
And then the last, of course, is the ideal test in terms of accuracy and precision.

00:06:06.440 --> 00:06:14.180
But I think clinicians are very interested in two other characteristics, and this is sensitivity and specificity.

00:06:14.180 --> 00:06:18.540
and they actually are the determinants of whether a test is accurate.

00:06:19.660 --> 00:06:24.900
So a sensitive test is able to identify everyone who has the illness.

00:06:25.820 --> 00:06:29.140
A specific test is available to identify those who don't,

00:06:30.080 --> 00:06:32.060
and both are cutoff dependent,

00:06:32.320 --> 00:06:36.760
and you can think of them as opposite ends of a teeter-totter,

00:06:37.360 --> 00:06:40.060
and the fulcrum is the cutoff value.

00:06:40.640 --> 00:06:42.140
So let me show you what I mean.

00:06:42.140 --> 00:06:52.200
If we have a test where results can be anywhere from 0 to 100, and we set the cutoff at 50, it looks like it's favoring specificity over sensitivity.

00:06:52.840 --> 00:06:57.840
But if I shift that fulcrum down to 30, I'm going to have more positive results.

00:06:58.320 --> 00:07:00.280
So I'm going to raise sensitivity.

00:07:00.680 --> 00:07:04.180
But unfortunately, some of those positives are false positives.

00:07:04.640 --> 00:07:06.400
And so specificity goes down.

00:07:06.400 --> 00:07:11.560
If I move that fulcrum in a different direction, I am going to get fewer positives.

00:07:12.140 --> 00:07:14.220
So specificity is gonna go up

00:07:14.220 --> 00:07:16.880
because there'll be fewer false positives,

00:07:16.880 --> 00:07:19.860
but I'm going to increase false negatives

00:07:19.860 --> 00:07:22.340
and so sensitivity goes down.

00:07:22.340 --> 00:07:27.520
So it really does matter where that cutoff is.

00:07:27.520 --> 00:07:31.920
Now, this two by two table shows us disease state

00:07:31.920 --> 00:07:35.000
in columns, positive and then negative.

00:07:35.000 --> 00:07:39.020
And in the rows, you're seeing test results.

00:07:39.020 --> 00:07:41.520
And so the boxes are labeled

00:07:41.520 --> 00:07:44.620
based on whether the test results actually agree

00:07:44.620 --> 00:07:46.600
with the disease state.

00:07:46.600 --> 00:07:49.020
And we can then plug that into equations

00:07:49.020 --> 00:07:54.430
for sensitivity and specificity.

00:07:54.430 --> 00:07:57.070
Sometimes people are interested in predictive value,

00:07:57.070 --> 00:07:59.410
so you can have a positive predictive value

00:07:59.410 --> 00:08:01.250
or a negative predictive value.

00:08:02.250 --> 00:08:04.830
And this is an answer to the question,

00:08:04.830 --> 00:08:07.190
how likely is this positive result,

00:08:08.370 --> 00:08:10.450
something that I can hang my hat on?

00:08:10.450 --> 00:08:13.750
And so people want to know positive result

00:08:13.850 --> 00:08:21.810
Well, a positive predictive value is the proportion of people who have a positive test and actually have the disease.

00:08:22.510 --> 00:08:24.130
And a negative predictive value

00:08:24.130 --> 00:08:25.550
is the proportion of people

00:08:25.550 --> 00:08:27.690
who have a negative test and don't have the

00:08:27.690 --> 00:08:29.730
disease. And so that sounds

00:08:29.730 --> 00:08:31.730
wonderful, but the trouble with predictive

00:08:31.730 --> 00:08:33.510
values, if you look at that equation,

00:08:33.670 --> 00:08:35.570
is you have to know the prevalence

00:08:35.570 --> 00:08:36.550
of disease.

00:08:37.210 --> 00:08:39.330
And unfortunately, that data is not

00:08:39.330 --> 00:08:41.010
available to clinicians.

00:08:41.850 --> 00:08:43.070
And prevalence really matters.

00:08:43.070 --> 00:08:49.610
And here's an example. If we start with a test in an area of 1,000 patients and the prevalence is

00:08:49.610 --> 00:08:55.090
only 10 percent, the table fills out like that. And you can see that the predictive

00:08:55.090 --> 00:09:02.110
value of a positive test is not that great at 64 percent. But if the prevalence of the disease

00:09:02.110 --> 00:09:08.410
increases to 30 percent, now you see a significant increase in the predictive value of

00:09:08.410 --> 00:09:19.120
positive test. In many infections, we can have direct evidence of the organism in question.

00:09:19.880 --> 00:09:26.520
So, direct tests identify the pathogen. Some examples are culture, microscopy,

00:09:26.920 --> 00:09:34.320
PCR, and antigen capture, and we use those in other diseases. There's also indirect evidence

00:09:34.320 --> 00:09:40.560
of infection. So, indirect tests actually are measuring the host response to the pathogen,

00:09:40.560 --> 00:09:43.000
for not measuring the pathogen itself.

00:09:43.680 --> 00:09:47.120
And so many of them are tests of immune activation,

00:09:47.640 --> 00:09:50.660
but some of them look for byproducts of the infection.

00:09:53.080 --> 00:09:57.200
In Lyme disease, it's hard to come by direct evidence.

00:09:58.240 --> 00:10:00.620
Culture and microscopy are not offered,

00:10:00.780 --> 00:10:02.100
and because it's too difficult,

00:10:02.860 --> 00:10:06.820
culture in Borrelia is problematic.

00:10:07.480 --> 00:10:10.120
You need special media with precise growing conditions,

00:10:10.120 --> 00:10:16.320
conditions, and it's a long incubation time. So it's just impractical for labs to offer that.

00:10:16.960 --> 00:10:25.740
A microscopy is a difficult, special stage, very few spirochetes in tissues, and so it's kind of

00:10:25.740 --> 00:10:30.620
like searching for the needle in the haystack. And I think as Dr. Embers mentioned, you know,

00:10:30.660 --> 00:10:36.940
it takes a lot of technical expertise, and I think at one point she said she went through 400 slides

00:10:36.940 --> 00:10:43.420
to find Borrelia. So you can see why that's not awkward. Good news is you can get PCR.

00:10:44.060 --> 00:10:54.300
So these are screenshots from LabCorp, Quest, and Mayo Laboratories. And PCR and positivity is great.

00:10:54.300 --> 00:11:01.900
It's direct evidence of the current infection. You can have multiple specimens that you can try

00:11:01.900 --> 00:11:11.660
to test with PCR so serum spinal fluid synovial fluid and even um tissue biopsies can be tested

00:11:11.660 --> 00:11:18.300
like maybe if you're biopsied and rash um but there's low sensitivity and so you can see the

00:11:18.300 --> 00:11:26.940
various values there um it's highest in synovial fluid but serology is is better than that so PCR

00:11:26.940 --> 00:11:33.280
testing, when positive is great, when negative doesn't really tell you much. PCR tests, as far

00:11:33.280 --> 00:11:42.070
as I know, have not been cleared by the FDA. So they're kind of in-house tests. So what are

00:11:42.070 --> 00:11:47.470
clinicians left with? Well, we're left with serology. And that's the enzyme immunoassays,

00:11:47.710 --> 00:11:54.490
the EIAs, or some of you know them as ELISAs, and then Western blots or immunoblots. And they're

00:11:54.490 --> 00:11:56.430
measuring, there are indirect

00:11:56.430 --> 00:11:57.890
tests and they are measuring

00:11:57.890 --> 00:11:59.870
antibody levels to

00:11:59.870 --> 00:12:02.710
and there

00:12:02.710 --> 00:12:04.210
are many manufacturers

00:12:04.210 --> 00:12:06.310
and dozens of tests on the market

00:12:06.310 --> 00:12:08.310
and the antigens that are used

00:12:08.310 --> 00:12:08.950
in the tests

00:12:08.950 --> 00:12:11.950
these are all FDA

00:12:11.950 --> 00:12:14.250
clear tests and that means

00:12:14.250 --> 00:12:16.190
that when they were trying

00:12:16.190 --> 00:12:17.930
to get on the

00:12:17.930 --> 00:12:19.770
market, they had to demonstrate that they

00:12:19.770 --> 00:12:21.690
were comparable to testing

00:12:21.690 --> 00:12:23.810
that was already out there. They did

00:12:23.810 --> 00:12:29.850
not have to demonstrate clinical validity. There are also something called lab-developed

00:12:29.850 --> 00:12:35.470
tests. These are tests that are designed, manufactured, and used in the lab that created

00:12:35.470 --> 00:12:46.570
them. So this is an even more simplified version of the antibody formation timeline in untreated

00:12:46.570 --> 00:12:53.270
patients. And I really just want to show you that the IgM levels go up first, usually between

00:12:53.270 --> 00:12:57.830
one to two weeks and then peak about four to six weeks and

00:12:57.830 --> 00:13:02.630
then they decline as that IgG begins to rise and we have class

00:13:02.630 --> 00:13:08.790
switching from IgM to IgG. IgG goes up and we think stays up

00:13:08.790 --> 00:13:17.890
indefinitely in the ongoing. Now in 1994 the CDC conducted a

00:13:17.890 --> 00:13:21.330
convened a meeting said you know what we gotta all get on

00:13:21.330 --> 00:13:27.570
the same page about tests because prior to that different institutions were using different tests

00:13:27.570 --> 00:13:33.170
they were interpreting Western blots differently and was causing confusion so a patient could be

00:13:33.730 --> 00:13:41.170
Lyme be a Lyme patient at Yale and not be a Lyme patient at Stone and so they've got people

00:13:41.170 --> 00:13:47.090
together and hashed out what's going to be the test procedures and how we're going to interpret

00:13:47.090 --> 00:13:52.170
Western blots. And that makes sense, especially because, you know, the CDC is in the business

00:13:52.170 --> 00:13:57.170
of epidemiology. You know, you have to understand a disease before you can prevent it

00:13:57.170 --> 00:14:03.090
and treat it. And so they wanted to make sure that they were counting actual caseloads of

00:14:03.090 --> 00:14:12.210
Lyme disease. And so they required a test that was specific. But inherent in their decisions

00:14:12.210 --> 00:14:18.490
were some assumptions about the immune response, specifically that it would be the same regardless

00:14:18.490 --> 00:14:26.790
of patient circumstances. And so that may or may not be true. So here's the two-tier testing

00:14:26.790 --> 00:14:34.770
algorithm. So if you order a Lyme test on your patient, the patient sample will first be tested

00:14:34.770 --> 00:14:42.290
with an EIA. And samples that are negative, we stop. But samples that aren't positive can either

00:14:42.290 --> 00:14:49.670
be tested with immunoblots, which is the standard two-tier testing. Or there's a newer way to

00:14:49.670 --> 00:14:58.250
approach, and that's to test with a second EIA, different than the first, and then that's either

00:14:58.250 --> 00:15:07.090
read as a positive or negative. Now, what I liked in the old diagram that the CDC had was it popped

00:15:07.090 --> 00:15:14.550
if you had a negative EIA, they had the word consider alternative diagnosis, as well you

00:15:14.550 --> 00:15:23.840
should. But this, to my mind, is very different than saying it's not Lyme. In immunoblots, we have

00:15:23.840 --> 00:15:29.880
some special rules on how to interpret them. So if someone's been ill for less than 30 days,

00:15:30.340 --> 00:15:35.800
you do IgM and IgG, and if either one are positive, that's a positive case.

00:15:35.800 --> 00:15:50.480
For people who have been ill for 30 days or more, the rule became you do the IgM and the IgG, but if the IgGs are not positive, it doesn't matter what the IgMs show.

00:15:50.780 --> 00:15:57.600
So positive IgMs after 30 days without IgG positivity, those are false positives.

00:15:58.480 --> 00:16:00.040
And so that's what became accepted.

00:16:02.240 --> 00:16:05.140
Now, two-tier testing is sequential testing.

00:16:05.140 --> 00:16:20.880
And it's really a neat idea. You're going to use a very sensitive test to capture a wide range of patients, and then you'll use a more specific second test to kind of narrow things down to throw out those false positives.

00:16:21.820 --> 00:16:31.920
When you test in this sequence, what happens is that the sensitivity of the two-test sequence is always lower than the sensitivity

00:16:31.920 --> 00:16:38.740
of the second test, and the specificity is always greater, and I'm going to demonstrate it here.

00:16:40.060 --> 00:16:46.240
So another table, we've got 200 patients, and half of them have disease. These are the parameters

00:16:46.240 --> 00:16:54.740
of the first test. Our little two-by-two grid fills out like this. There's 110 people who tested

00:16:54.740 --> 00:17:00.460
positive. 20 of those are false positives, and unfortunately, we missed 10 people,

00:17:00.460 --> 00:17:06.700
Well, we're only going to test the 110, and so if we use a test that is less sensitive

00:17:06.700 --> 00:17:14.300
but more specific, we actually create another 18 false positives, and we have been able

00:17:14.300 --> 00:17:22.780
to successfully winnow down 18 false negatives, and got the false positives down to one.

00:17:22.780 --> 00:17:30.060
So in this sequence, testing was only 72% sensitive, but was 99% specific.

00:17:30.460 --> 00:17:35.220
Here's a cartoon on how that first EIA is done.

00:17:35.220 --> 00:17:38.560
This is with the original one with a whole cell sonicate.

00:17:38.560 --> 00:17:43.160
You're breaking up that bacteria into its various antigens that get embedded in the

00:17:43.160 --> 00:17:45.240
well of the test well.

00:17:45.240 --> 00:17:51.020
And then patient specimens are added, and you can see those little Ys, if they can attach

00:17:51.020 --> 00:17:55.420
to an antigen, those are antibodies, they'll be bonded.

00:17:55.420 --> 00:18:00.740
And we wash that away so the free antibodies go away, and we add a second antibody.

00:18:00.920 --> 00:18:07.840
Now, this is an anti-human antibody, so it's going to bind to the antibodies that remain in the test well.

00:18:07.840 --> 00:18:17.020
And it's called TAG, and TAG means that it's got an enzyme on it that will react with the substrate and cause a color change.

00:18:17.020 --> 00:18:28.620
And so, ultimately, you get a color change that can be read and then ultimately converted to an antibody concentration.

00:18:29.200 --> 00:18:38.010
So, newer tests, newer EIAs are using synthetic or recombinant antigens.

00:18:38.130 --> 00:18:40.470
So, in this case, we're using the C6.

00:18:40.470 --> 00:18:42.750
So, it's the only antigen in the well.

00:18:43.510 --> 00:18:50.290
You can put patient specimens in there, and there might be other antiviral antibodies, but they have nothing to attach to.

00:18:50.730 --> 00:18:52.270
So they'll get washed away.

00:18:52.390 --> 00:18:56.510
And then the rest of the procedure is similar to what I just showed.

00:18:59.870 --> 00:19:01.610
Immunoblots are different.

00:19:01.950 --> 00:19:04.450
So Western blots and Lyme blots are

00:19:04.450 --> 00:19:07.230
different at how they look for antibodies.

00:19:07.770 --> 00:19:11.770
Here, they're actually looking for a specific group of antibodies.

00:19:12.470 --> 00:19:14.490
And this is a very detailed process.

00:19:14.490 --> 00:19:19.910
And it begins by breaking up the Borrelia into different antigens

00:19:19.910 --> 00:19:22.050
and separating them on a gel.

00:19:22.050 --> 00:19:28.410
And so it's a very labor-intensive process, and there's potential bands.

00:19:28.570 --> 00:19:29.850
There are dozens of them.

00:19:30.610 --> 00:19:35.430
And so this becomes very cumbersome to evaluate and actually look at.

00:19:36.270 --> 00:19:43.170
And so there are many performance issues that might add to imprecision of the Western blot, very tech-dependent.

00:19:43.250 --> 00:19:45.390
It's hard to get those antigens to separate.

00:19:45.390 --> 00:19:51.530
And then looking at the intensity of the bands, some of them, on this example, are very dark,

00:19:51.650 --> 00:19:54.010
where others are very, very light.

00:19:55.090 --> 00:19:59.670
And these tests take a long time to get, so you don't get your answer back the next day,

00:19:59.730 --> 00:20:01.410
which is really what you'd like.

00:20:03.570 --> 00:20:09.530
The newer immunoblots are line blots, and what they do is they use recombinant or purified

00:20:09.530 --> 00:20:14.250
antigens, and they can put the exact same amount on each test.

00:20:14.250 --> 00:20:21.310
So you have uniformity there, and they can put the antigens wherever they want.

00:20:21.710 --> 00:20:26.470
They can often do it so that it mimics the alignment of a Western blot.

00:20:27.110 --> 00:20:31.650
And the sample is added, and it's very similar to how the Western blots are performed.

00:20:32.190 --> 00:20:40.530
The big advantage of the immunoblots, it's going to reduce the clutter that we saw in the whole cell sonicate Western blot.

00:20:40.530 --> 00:20:52.250
So back at that 1994 conference, they told you how to do the two-tier sequence, and they also said how to interpret the immunoblots, and

00:20:52.250 --> 00:21:01.710
they wanted it to be very specific. So they took criteria from a study by Engstrom, and here they're only interested in three potential bands.

00:21:01.710 --> 00:21:07.410
You had to have two of the three. And then for the IgG immunoblots, they took

00:21:07.410 --> 00:21:13.730
criteria from a study by Dressler. Now we're looking for potentially 10 different bands that

00:21:13.730 --> 00:21:23.990
we can assess, and you need to have at least five. So some examples of positive IgM, you can see that

00:21:23.990 --> 00:21:30.670
all three samples, one through three, meet the criteria, and that unfortunately four through six

00:21:30.670 --> 00:21:37.670
do not. And indeterminate are the bands that they just couldn't break. It's hard to know sometimes

00:21:37.670 --> 00:21:41.250
if something's really there or if it's just a very faint.

00:21:42.430 --> 00:21:46.710
And so now when we switch to look at the results from an IgG,

00:21:46.890 --> 00:21:51.110
we've got 10 bands to consider, and we want to have five.

00:21:51.210 --> 00:21:53.650
And that's what you see in samples one through six.

00:21:54.250 --> 00:21:56.450
Now, samples four through six are negative,

00:21:56.690 --> 00:21:59.230
but my eye was caught by sample four

00:21:59.230 --> 00:22:02.850
because those four bands are really lighting up.

00:22:02.850 --> 00:22:06.930
The little blue pluses have to do with signal intensity.

00:22:06.930 --> 00:22:12.170
So, the darker the band on the plot or immunoblot, the higher the intensity.

00:22:12.770 --> 00:22:16.390
But intensity is not part of the interpretation criteria.

00:22:18.230 --> 00:22:20.150
So, what do you choose?

00:22:20.390 --> 00:22:23.470
Do you want to do standard two-tier testing or modified?

00:22:23.850 --> 00:22:31.530
Well, modified two-tier testing is thought to be more sensitive in early Lyme disease, so that might be ideal then.

00:22:31.530 --> 00:22:46.890
I, as a clinician, think you get a little bit more information from a standard two-tier testing, especially when the test is negative, because some tests, to my eye, are worth considering or giving a second look.

00:22:47.610 --> 00:22:52.490
This is especially true if you've done your differential and you've tested for the other

00:22:52.490 --> 00:22:55.750
items that you thought might be causing your patient's illness.

00:22:56.270 --> 00:23:01.430
And if you haven't found anything, you might want to come back and say, well, am I being

00:23:01.430 --> 00:23:03.290
too picky about this Western blot?

00:23:03.710 --> 00:23:07.570
Because it turns out there are other Western blot schemes.

00:23:08.270 --> 00:23:14.170
And so they differ on which bands to count, how many you need to have, and whether some

00:23:14.170 --> 00:23:16.330
bands are more important than others.

00:23:18.810 --> 00:23:26.650
Earlier I said that when they selected the two-test sequence and the Western blot

00:23:26.650 --> 00:23:34.540
interpretation that there were some assumptions were made. And so it's my general nature to

00:23:34.540 --> 00:23:41.820
question assumptions, so here we go. The first assumption was that the timing of the IgG

00:23:41.820 --> 00:23:48.220
response was going to be the same across the board, and that's why you had that ignore IgMs

00:23:48.220 --> 00:23:54.480
after one month. But as this quote from Dr. Branda points out, experience is a wonderful

00:23:54.480 --> 00:24:00.460
teacher, and now we know that it can take up to two months for patients to develop an IgG response.

00:24:01.200 --> 00:24:10.680
So, we know the timing of IgG is variable. Another assumption was that there's no impact

00:24:10.680 --> 00:24:16.800
on the patient's immune status when they contracted Lyme disease. We know that immunosuppression

00:24:16.800 --> 00:24:23.400
reduces antibody formation. So, if you have the misfortune of being on chemo for a B-cell cancer

00:24:23.400 --> 00:24:28.040
and you happen to contract Lyme disease, you're not going to mount a response.

00:24:28.740 --> 00:24:35.400
What I couldn't describe from the literature was the impact of corticosteroids. You know,

00:24:35.500 --> 00:24:40.300
most of these trials are small, and so it's great that we have people like Dr. Aucott

00:24:40.300 --> 00:24:45.520
really starting to accumulate patients because you would need a very large patient population

00:24:45.520 --> 00:24:48.600
to then look at the subpopulation of people

00:24:48.600 --> 00:24:51.440
who were on steroids when they got their Lyme disease.

00:24:51.940 --> 00:24:53.300
So that work hasn't been done.

00:24:55.650 --> 00:24:59.850
Another assumption is that the immune response

00:24:59.850 --> 00:25:03.190
would be the same regardless of the clinical presentation.

00:25:04.170 --> 00:25:06.810
And so I'm going to show you two tests that made me,

00:25:07.010 --> 00:25:09.030
or two studies that made me question that.

00:25:09.550 --> 00:25:13.450
So I looked at this paper from Bacon's group,

00:25:13.830 --> 00:25:16.930
and they were looking at how the C6 performs.

00:25:17.150 --> 00:25:24.650
And here you find that when it came to Lyme arthritis, it was 94% sensitive, great test.

00:25:25.190 --> 00:25:29.990
But for late neurologic disease, it was only 73% sensitive.

00:25:32.910 --> 00:25:39.210
And then Dressler's paper, which was the one where we got our 5 of 10 criteria, that

00:25:39.210 --> 00:25:40.970
was a retrospective study.

00:25:41.450 --> 00:25:46.190
So then in the same paper, they reported the results from a prospective study.

00:25:46.190 --> 00:25:53.210
and they were using their own well-characterized patients. And what they did is they took the

00:25:53.210 --> 00:26:00.710
arthritis and neuroborreliosis. And here in this table, they started with 25 with arthritis and 29

00:26:00.710 --> 00:26:09.970
with neuroborreliosis. But it turns out that 24 were four of the 29 neuroborreliosis patients

00:26:09.970 --> 00:26:15.890
or early. So I removed them and I redone the table. And now you can see that the sensitivity

00:26:15.890 --> 00:26:23.450
for arthritis was still great, 96%, but there's a difference. Neuroborreliosis was only 84%

00:26:23.450 --> 00:26:29.850
sensitive. Now, this is theoretical. Well, what if we took the findings from Bacon C6

00:26:29.850 --> 00:26:38.810
and Dressler's IgG side and put them together? We would find that two-tier testing was 90%

00:26:38.810 --> 00:26:46.830
sensitive for Lyme arthritis, but only 61% for late neuroborreliosis. Now, that's in theory,

00:26:46.930 --> 00:26:51.630
but I think it's something that's worth pondering about, and I hope sometime we'll get to the point

00:26:51.630 --> 00:26:56.630
where someone's researching to see if there is actually a difference based on clinical

00:26:56.630 --> 00:27:02.410
presentation. Newer tests have much higher sensitivity, and if you read them, hey,

00:27:02.750 --> 00:27:08.150
we're 100% sensitive for late Lyme disease. That always got me wondering, well, how'd you pull

00:27:08.150 --> 00:27:15.890
that off. Dressler didn't do it. And so I think part of the issue is when they say late Lyme

00:27:15.890 --> 00:27:22.950
disease, they've lumped the two groups together. And the specimens that you're testing against are

00:27:22.950 --> 00:27:30.570
in a performance panel. And to be on a specimen labeled as late in a Performance Panel, you had

00:27:30.570 --> 00:27:37.030
to meet the lab criteria of the CDC definition. So basically, newer tests are finding what had

00:27:37.030 --> 00:27:45.730
already been found. And so what they didn't show us is does this bench sensitivity translate to

00:27:45.730 --> 00:27:51.430
clinical sensitivity? Is it clinically valid? And I also looked at a lot of the papers that

00:27:51.430 --> 00:27:57.250
were describing their results. And when you look at the panels that they were using,

00:27:57.590 --> 00:28:05.290
they were primarily Lyme arthritis. In the CDC's repository that you could test against,

00:28:05.290 --> 00:28:14.750
all of their patients were Lyme arthritis. So here again is that diagram of the antibody response

00:28:14.750 --> 00:28:21.770
in the untreated. And we'd assume that in untreated people that IgG persists indefinitely.

00:28:22.630 --> 00:28:27.390
But we don't know that for sure, because as soon as we find someone, we treat them.

00:28:28.070 --> 00:28:33.790
You know, we can't ethically just say, oh, I'm going to follow you along and see what happens

00:28:33.790 --> 00:28:47.830
So we can turn to animal studies, and Dr. Embers' study in 2012 was interesting in that she had 12 monkeys that were not treated.

00:28:48.010 --> 00:28:57.930
They were infected, but not treated, and wouldn't you know, they all were C6 positive right at five to eight weeks as we would want, and that's what we would expect.

00:28:57.930 --> 00:29:09.630
But then over the course of the next 80 to 90 weeks, in 7 of the 12, or 58%, the C6 reaction became undetectable.

00:29:09.890 --> 00:29:24.550
So it raises the question of, do we have people out there who are untreated with a smoldering infection, but who we can't diagnose if we're reliant exclusively on serology?

00:29:24.550 --> 00:29:31.770
Another assumption is that the results are precise doesn't matter what test you get

00:29:31.770 --> 00:29:37.270
a positive is a positive and a negative is a negative well here we see that this

00:29:37.270 --> 00:29:45.290
group of tests were being tested against the reference labs a reference test and the reference

00:29:45.290 --> 00:29:50.230
test to decide determine whether a test was positive or negative happened to be the Marblot

00:29:50.230 --> 00:30:03.690
But when these researchers used the Marblot against the same samples that the reference lab tested, they were only 85% sensitive for IgG and only 62% for the IgM.

00:30:03.910 --> 00:30:08.550
So replication of results is difficult with Western blots.

00:30:08.550 --> 00:30:17.310
And just to point out that they use the term relative sensitivity and relative specificity as kind of non-standard terminology,

00:30:17.670 --> 00:30:28.170
but because they're doing their comparison against a reference value that may also have missed culture positive cases, this is appropriate terminology.

00:30:28.770 --> 00:30:37.710
So here we have the same lab using the same samples, but different tests.

00:30:37.710 --> 00:30:43.850
And you can see that there's quite a difference between the first and the next two in terms of sensitivity.

00:30:45.390 --> 00:30:55.790
Now, the good news is that those line blots should improve precision because they're eliminating a lot of the technical errors that can occur when you're making a blot.

00:30:59.230 --> 00:31:03.430
People often wonder, what about serology after someone's been treated?

00:31:04.010 --> 00:31:06.830
especially the people who remain ill,

00:31:07.250 --> 00:31:09.990
will it be of any value to test them again?

00:31:10.670 --> 00:31:12.550
And the answer is no, it won't.

00:31:12.890 --> 00:31:15.230
And that's because negative results

00:31:15.230 --> 00:31:17.690
don't indicate that the person is clean.

00:31:18.330 --> 00:31:20.710
We know that antibody values declined

00:31:20.710 --> 00:31:22.750
over time after treatment.

00:31:23.590 --> 00:31:26.270
And positive results don't mean that they're infected

00:31:26.270 --> 00:31:29.530
because that duration of the antibody response

00:31:29.530 --> 00:31:31.690
is highly variable and unpredictable.

00:31:31.690 --> 00:31:39.770
And I know where I live in Minnesota, a lot of doctors think once you're positive, you'll always be positive on testing.

00:31:39.930 --> 00:31:45.770
And that's not true. In most patients, the antibody response will eventually go away.

00:31:48.500 --> 00:31:53.300
So what's the nuts and bolts of testing? What are you going to do in your clinic?

00:31:53.500 --> 00:31:59.080
So if someone walks in with a tick bite, won't that be fun to take that out?

00:31:59.080 --> 00:32:05.720
but should you test them? Well, it's too soon for that antibody, so don't make the mistake of

00:32:05.720 --> 00:32:12.340
testing, because if you test and you happen to get a positive result, that's really evidence of

00:32:12.340 --> 00:32:18.920
higher exposure, and I don't think it's coming from that particular bite. And similarly, in people

00:32:18.920 --> 00:32:23.840
with post-treatment Lyme disease or persistent Lyme diseases, whatever term you're going to use,

00:32:23.840 --> 00:32:32.040
We know that antibiotics can change the immune response, and so whatever you get is not going to be a reliable indicator.

00:32:32.240 --> 00:32:36.120
So testing really won't help me, at least not serology.

00:32:37.540 --> 00:32:46.860
Now, Lyme arthritis is interesting, and that's because more and more, it seems that people are showing up with arthritis without a preceding erythema migrans.

00:32:46.860 --> 00:32:54.900
and they also there's not seasonality to Lyme arthritis it can occur within just a couple months

00:32:54.900 --> 00:33:02.020
of being bitten by a tick or might emerge years later and so that makes it a trickier diagnosis

00:33:02.020 --> 00:33:07.800
based on clinical grounds but you want to be able to separate out someone who has Lyme

00:33:07.800 --> 00:33:13.820
arthritis versus someone who is a different bacteria causing their septic joint and so here

00:33:13.820 --> 00:33:20.860
testing is quite valuable because it has high specificity and high sensitivity. So test away

00:33:20.860 --> 00:33:29.160
if you're worried about Lyme arthritis. In these situations, Lyme disease testing can be useful

00:33:29.160 --> 00:33:35.380
when it's positive because especially in an endemic state like Delaware, if someone comes in

00:33:35.380 --> 00:33:44.740
with AV block who's had exposure or a facial nerve palsy or a smoldering type of meningitis,

00:33:44.740 --> 00:33:47.980
or even those adults who get the summertime flu,

00:33:48.580 --> 00:33:51.980
if they test positive, you can trust that that's a true positive.

00:33:52.480 --> 00:33:55.560
Same with people who present with late neuroborreliosis.

00:33:56.460 --> 00:33:59.120
Remember that in very early cases,

00:33:59.300 --> 00:34:03.880
it might be that the modified two-tier testing would be more sensitive.

00:34:04.920 --> 00:34:07.460
The trick here is if you get negative results,

00:34:07.920 --> 00:34:10.780
don't throw away the idea that this could be Lyme

00:34:10.780 --> 00:34:14.300
because you might find out once you work through your differential

00:34:14.300 --> 00:34:17.460
that Lyme makes more sense than anything else.

00:34:19.420 --> 00:34:25.140
Do not test if you see someone with an erythema migrans rash.

00:34:25.660 --> 00:34:27.920
It's not the pathogen of Lyme,

00:34:28.000 --> 00:34:31.160
but because we do know that STARI and other things

00:34:31.160 --> 00:34:33.100
can cause a similar appearing rash.

00:34:33.420 --> 00:34:36.320
But it is a hallmark lesion of early Lyme disease,

00:34:36.840 --> 00:34:41.540
and you don't want to delay treatment and be confused by test results

00:34:41.540 --> 00:34:49.300
because, as you see from Dr. Horn's study, she had only 29% of the people that had definitely

00:34:49.300 --> 00:34:56.960
had an EM rash were two-tier positive. And so, use your clinical judgment, look at the clinical

00:34:56.960 --> 00:35:06.320
evidence, and then make your diagnosis. One of the tricky ones are people who fail to do Lyme

00:35:06.320 --> 00:35:11.460
prevention, and they've got Lyme not only once, but perhaps twice. And, so, you're trying to

00:35:11.460 --> 00:35:18.320
discern if someone comes in with an EM rash with a history of Lyme disease. Is this a new case and

00:35:18.320 --> 00:35:24.680
they've been reinfected or are they simply having a relapse of their disease? Because both can occur.

00:35:26.160 --> 00:35:32.620
Testing here is tricky. If you want to look at the details, one of the references is to Dr.

00:35:32.620 --> 00:35:38.460
Branda's 2021 paper. He does a nice section on

00:35:38.460 --> 00:35:42.940
reinfection versus relapse. So this is when you're going to rely more on

00:35:42.940 --> 00:35:47.260
clinical information. Did the patient have a new exposure history?

00:35:47.260 --> 00:35:52.780
Did their EM rash, is it in the

00:35:52.780 --> 00:35:56.380
a different location than their previous EM rash?

00:35:56.380 --> 00:35:59.340
Do their symptoms, are they different in this

00:35:59.340 --> 00:36:02.100
in illness than in their previous.

00:36:02.100 --> 00:36:04.720
If the EM rash is at the same place,

00:36:04.720 --> 00:36:07.540
then that speaks more likely to a relapse

00:36:07.540 --> 00:36:11.520
because it would be, I hope, unusual for an EM

00:36:11.520 --> 00:36:17.120
to be exactly in the same location on reinfection.

00:36:17.120 --> 00:36:21.000
So to summarize, current testing,

00:36:21.000 --> 00:36:24.460
serologic testing for Lyme disease is limited

00:36:24.460 --> 00:36:28.400
because it's insensitive in certain situations.

00:36:28.400 --> 00:36:42.320
However, the specificity is wonderful, and so someone in Delaware with a good clinical history suggestive of Lyme disease and two-tier testing that's positive certainly supports the diagnosis.

00:36:42.640 --> 00:36:53.020
You always have to consider lab results in the context of an individual's risk factors, history, and exam findings.

00:36:53.020 --> 00:37:00.480
and until we have good direct tests of infection you're going to have to use your clinical judgment

00:37:00.480 --> 00:37:06.600
as you diagnose patients with Lyme disease. Thank you and I look forward to any questions.

00:37:06.960 --> 00:37:18.460
I can talk. Okay.

00:37:20.540 --> 00:37:28.120
So just a little bit of a I guess a technical question about the Western blot. I remember

00:37:28.120 --> 00:37:32.880
one of your slides you had like the numbers for a patient had like 39 kilodaltons there was

00:37:32.880 --> 00:37:41.220
a band or whatever so like i guess so you're my teacher if i see a band at 39 kilodaltons and that

00:37:41.220 --> 00:37:44.940
band is there that's from Western blot that had a secondary antibody and stuck to a first

00:37:44.940 --> 00:37:48.420
antibody that was created against the protein that's the rolling protein how is that negative

00:37:48.420 --> 00:37:53.720
just in a generic like because i like it's the part you're saying about there's four bands but

00:37:53.720 --> 00:37:59.540
how can there be a band and still be negative if that does that make sense i understand what

00:37:59.540 --> 00:38:05.380
you're asking because you're you're saying hey this is an important band 39 and it's showing up

00:38:05.380 --> 00:38:13.120
um why would i not just on the basis of that say that my patient has Lyme disease and it you know

00:38:13.120 --> 00:38:20.380
some of these antibodies antigens cross-react with other uh infectious agents and so that's why

00:38:20.380 --> 00:38:26.380
they don't hang their hat on a single band and that's they really want to be specific so that'S

00:38:26.380 --> 00:38:34.540
they came up with the five or ten criteria but other um schemes for interpreting Western blots

00:38:34.540 --> 00:38:41.740
do say you know you these two bands are important um and that they're sufficient for a diagnosis

00:38:41.740 --> 00:38:49.500
but what was decided on at the 1994 conference was you had to have this type of band pattern

00:38:49.500 --> 00:38:54.890
oh but that makes sense thank you i don't need it either sorry

00:38:54.890 --> 00:39:02.410
if you've got five of those ten that are positive and you have the

00:39:02.410 --> 00:39:07.770
Western blot that's also interpreted as positive is there any way that that could be a false positive

00:39:11.370 --> 00:39:18.730
sure so the question is if you got a positive uh Western blot so uh the first two tests

00:39:18.730 --> 00:39:25.530
first tier test was positive and now you have the positive uh Western blot um is there any way that

00:39:25.530 --> 00:39:31.210
that could be a false positive well yes so you know if you do the numbers there's like a less

00:39:31.210 --> 00:39:38.730
than one percent chance uh that that's a false positive uh but that means there's a 99 chance

00:39:38.730 --> 00:39:48.070
that it didn't so especially in endemic states you do want to trust the positive results yes

00:39:48.070 --> 00:39:53.110
I have a question about Lyme arthritis. How do you determine if the testing is negative

00:39:53.110 --> 00:39:57.990
if the patient wasn't treated and they have arthritis syndrome but she's not in the toilet?

00:39:59.830 --> 00:40:03.190
Oh darn. So the question was how do you

00:40:03.190 --> 00:40:07.750
determine osteoarthritis from Lyme arthritis if the test is negative?

00:40:08.710 --> 00:40:11.430
You know the testing was so good for Lyme

00:40:11.430 --> 00:40:17.190
arthritis that I would not think that you're getting a false negative.

00:40:17.190 --> 00:40:20.870
I think that you have to trust that test that they don't have Lyme arthritis.

00:40:21.310 --> 00:40:26.510
It does get trickier as people age because we do develop osteoarthritis.

00:40:28.110 --> 00:40:34.070
When I was practicing, I'm not practicing now, but when young people came in with their Lyme

00:40:34.070 --> 00:40:36.930
arthritis, they were always positive.

00:40:37.270 --> 00:40:43.610
And the other interesting thing about Lyme arthritis versus osteo, the joint can really blow up.

00:40:44.270 --> 00:40:45.850
And yet they kind of hobble in.

00:40:45.850 --> 00:40:53.310
Whereas if you have septic arthritis from another cause, they're not hobbling and they're coming in in a wheelchair.

00:40:53.850 --> 00:41:03.130
And so there usually is clinical difference between osteoarthritis, Lyme arthritis, and then at the extreme end is septic arthritis.

00:41:08.270 --> 00:41:08.870
All right.

00:41:09.130 --> 00:41:10.670
Take the mic to the person in the short.

00:41:10.870 --> 00:41:11.250
Thank you.

00:41:13.420 --> 00:41:21.200
Something that I've read on false positives was having previous diagnoses of mononucleosis.

00:41:21.640 --> 00:41:24.940
Is that something that you could maybe expand on just a little bit?

00:41:25.240 --> 00:41:25.600
Well, sure.

00:41:25.820 --> 00:41:30.530
So there are cross-reacting antibodies.

00:41:30.830 --> 00:41:40.050
So if we think of bacteria, they can have similar antigens on their surface, or in this

00:41:40.050 --> 00:41:41.470
case with mono or virus.

00:41:41.830 --> 00:41:47.610
And so you can get cross-reacting antibodies, and so that is another reason why they didn't

00:41:47.610 --> 00:41:54.110
hang their hat on a single antibody, but actually had to say, you know, you have to have more than

00:41:54.110 --> 00:42:02.930
one. But what you're getting at is an interesting point. And so specificity is great if you're an

00:42:02.930 --> 00:42:08.730
epidemiologist or a clinical researcher, because you need to make sure that you're not counting

00:42:08.730 --> 00:42:15.450
or studying people who don't have your disease. But a clinician, you want to have sensitive tests

00:42:15.450 --> 00:42:20.490
because you're trying to find anyone who might benefit from your therapeutic intervention.

00:42:21.170 --> 00:42:24.490
And so there's kind of a dynamic tension between the two.

00:42:25.470 --> 00:42:31.710
I'm also very cognizant that we don't want to give people a label of Lyme disease if they have something else.

00:42:32.150 --> 00:42:36.630
When I speak to the public, I always say the goal is not to be diagnosed with Lyme

00:42:36.630 --> 00:42:41.390
disease. It's to be diagnosed correctly. And so that's that's the basis.

00:42:41.390 --> 00:42:51.430
but yes um obviously with a lot of research that you're referencing also is being referenced by a

00:42:51.430 --> 00:42:56.310
lot of the other institutions that are teaching this thing um a lot stuff has happened since

00:42:56.310 --> 00:43:04.130
about 20 but the CDC is basing a lot if there are results on 799 is there any way that they're

00:43:04.130 --> 00:43:08.710
going to be updating things soon because it sounds like things have kind of gotten out of date and

00:43:08.710 --> 00:43:13.210
And with presentations like this, when it endures you soon, it looks like there's a

00:43:13.210 --> 00:43:18.250
lot of development in the Lyme world and in the CDC going to be hopefully updating things

00:43:18.250 --> 00:43:24.510
a little soon because the five-band testing protocol limitation is a problem.

00:43:25.490 --> 00:43:27.050
Do I need to repeat that?

00:43:27.290 --> 00:43:33.270
It's basically, is the CDC gonna be kind of modernizing their criteria?

00:43:34.010 --> 00:43:38.270
And I can't speak for the CDC, but I am gonna go to a round table that they're offering

00:43:38.270 --> 00:43:41.310
next week on their vector borne disease policy.

00:43:43.570 --> 00:43:49.570
You know, when I read these papers from the 90s and moving forward, it's always this promise

00:43:49.570 --> 00:43:52.510
of the test, the good test is right around the corner.

00:43:53.110 --> 00:43:57.210
And we're really needing testing to be direct testing, right?

00:43:57.610 --> 00:44:02.670
And so I think that we have other people in the room that can speak to the future of testing.

00:44:03.630 --> 00:44:06.170
Sadly, we're stuck right now with what we've got.

00:44:06.170 --> 00:44:13.010
But there again, that first thing I said, how testing doesn't occur in a vacuum.

00:44:13.770 --> 00:44:20.690
And so, yeah, sometimes you're going to move forward with treatment in someone who doesn't meet that two-tier standard.

00:44:21.350 --> 00:44:28.290
But what I would suggest to you is someone who's done a lot of peer review in general, whenever you're

00:44:28.290 --> 00:44:32.710
going off in a different direction, you just have to document your thinking quite well

00:44:32.710 --> 00:44:38.350
and so that people can follow how you arrive at the decision to test or treat

00:44:38.350 --> 00:44:42.490
when things aren't quite what they are told to do.

00:44:42.490 --> 00:44:58.310
My question is, in human medicine, do you have a vaccine approved for Lyme disease in particular?

00:44:58.810 --> 00:45:02.450
So the question is do we have a vaccine for Lyme disease?

00:45:02.450 --> 00:45:09.110
Not at the moment, but I've got my fingers crossed that there's some vaccines in development.

00:45:12.310 --> 00:45:19.090
I'm just curious, because in veterinary medicine, we have the Lyme vaccine for a long time already.

00:45:19.970 --> 00:45:23.410
Right. I know that. And there used to be a human vaccine.

00:45:23.910 --> 00:45:27.450
It was withdrawn from the market in 2002.

00:45:28.170 --> 00:45:33.310
And depending on who you listen to, there's various reasons for it being withdrawn.

00:45:33.310 --> 00:45:38.350
I think that we're careful about creating a vaccine.

00:45:38.550 --> 00:45:44.590
We don't want to cause injuries in a vaccine, so there is one being tested now.

00:45:44.670 --> 00:45:47.870
I think they might be in stage three clinical trials.

00:45:48.450 --> 00:45:56.490
So I really want a vaccine because it's really hard to get people to practice prevention,

00:45:57.290 --> 00:46:01.410
and so I think a vaccine is going to be very useful.

00:46:01.410 --> 00:46:07.800
So hopefully it'll be soon.

00:46:07.800 --> 00:46:08.640
All right.

00:46:08.640 --> 00:46:09.860
Well, it looks like I'm done.

00:46:09.860 --> 00:46:11.440
I want to thank you for your attention.

00:46:11.440 --> 00:46:12.280
Have a lovely.

